The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard.
Smith Indica THC18.5 CBD≤1 has been verified as meeting the minimum quality standard.
Smith Sativa THC18.5 CBD≤1 has been verified as meeting the minimum quality standard.
More information on the products can be found on the Ministry of Health website.
